Co-Diagnostics, Inc

mission statement co-diagnostics, inc (co-dx) was founded in 2013 with a mission to democratize access to molecular diagnostics, to transform healthcare delivery and to create a positive impact on a global scale by enabling availability of robust, high-quality, affordable polymerase chain reaction (“pcr”) technology—especially to regions of the world where the need is greatest. our patented co-primers™ technology is paving the way for innovation in disease detection and life sciences research, while we are preparing to launch an innovative at-home and point-of-care real-time pcr testing platform. the purpose of the new co-dx pcr pro™ instrument and tests is to make high-quality real-time pcr diagnostics (the gold-standard of infectious disease testing) widely accessible where it is needed most, including in remote areas, at the point-of-care or even at home, all at affordable prices.